The novel secretome ST266 activates Akt and protects against oxidative stress-mediated injury in human RPE and Müller cells

IF 3 2区 医学 Q1 OPHTHALMOLOGY
Alan C. Tang , Nicholas A. Besley , Rose Trimpey-Warfhatig , Ping Yang , Howard Wessel , Larry Brown , Ziv Kirshner , Glenn J. Jaffe
{"title":"The novel secretome ST266 activates Akt and protects against oxidative stress-mediated injury in human RPE and Müller cells","authors":"Alan C. Tang ,&nbsp;Nicholas A. Besley ,&nbsp;Rose Trimpey-Warfhatig ,&nbsp;Ping Yang ,&nbsp;Howard Wessel ,&nbsp;Larry Brown ,&nbsp;Ziv Kirshner ,&nbsp;Glenn J. Jaffe","doi":"10.1016/j.exer.2024.110060","DOIUrl":null,"url":null,"abstract":"<div><p>Oxidative stress-mediated retinal pigment epithelial (RPE) cell damage is associated with age-related macular degeneration (AMD). ST266 is the biological secretome produced by a novel population of amnion-derived multipotent progenitor cells. Herein, we investigated the effect of ST266 on RPE cell injury induced by hydroquinone (HQ), a cigarette smoke related oxidant, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and all-trans retinal (atRal), a pro-oxidant component of the retinoid cycle. We additionally investigated its effect on Müller cell injury induced by H<sub>2</sub>O<sub>2</sub>.</p><p>Cultured human RPE cells were pre-treated for 1 h in the presence or absence of MK-2206, a protein kinase B (Akt) inhibitor, then treated with varying concentrations of HQ, H<sub>2</sub>O<sub>2,</sub> or atRal for 1.5 h. Cultured human Müller cells (MIO-M1) were pre-treated for 1 h in the presence or absence of MK-2206, then treated with varying concentrations of H<sub>2</sub>O<sub>2</sub> for 1.5 h. Media were then replaced with STM100 (control media into which the ST266 secretome proteins were collected) or ST266 at various times. Cell viability was determined with WST-1 reagent. Mitochondrial membrane potential (Δψm) was quantified by a fluorescence plate reader. The protein phosphorylation levels of Akt, glycogen synthase kinase 3 beta (GSK-3β), and p70 ribosomal S6 kinase (p70S6K) were measured by Western blot.</p><p>ST266 significantly improved RPE and MIO-M1 cell viability that was reduced by oxidant exposure and improved oxidant-disrupted Δψm. In both cell types, ST266 induced phosphorylation of Akt, GSK-3β, and p70S6K. MK-2206 significantly eliminated ST266-mediated protein phosphorylation of Akt, GSK-3β, and p70S6K and abolished the ST266-protective effect on cell viability. In conclusion, ST266 activates Akt, protects against oxidative stress-mediated cell injury in an Akt-dependent manner, and improves Δψm, suggesting a potential role for ST266 therapy in treating retinal diseases such as AMD.</p></div>","PeriodicalId":12177,"journal":{"name":"Experimental eye research","volume":"248 ","pages":"Article 110060"},"PeriodicalIF":3.0000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental eye research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014483524002811","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Oxidative stress-mediated retinal pigment epithelial (RPE) cell damage is associated with age-related macular degeneration (AMD). ST266 is the biological secretome produced by a novel population of amnion-derived multipotent progenitor cells. Herein, we investigated the effect of ST266 on RPE cell injury induced by hydroquinone (HQ), a cigarette smoke related oxidant, hydrogen peroxide (H2O2) and all-trans retinal (atRal), a pro-oxidant component of the retinoid cycle. We additionally investigated its effect on Müller cell injury induced by H2O2.

Cultured human RPE cells were pre-treated for 1 h in the presence or absence of MK-2206, a protein kinase B (Akt) inhibitor, then treated with varying concentrations of HQ, H2O2, or atRal for 1.5 h. Cultured human Müller cells (MIO-M1) were pre-treated for 1 h in the presence or absence of MK-2206, then treated with varying concentrations of H2O2 for 1.5 h. Media were then replaced with STM100 (control media into which the ST266 secretome proteins were collected) or ST266 at various times. Cell viability was determined with WST-1 reagent. Mitochondrial membrane potential (Δψm) was quantified by a fluorescence plate reader. The protein phosphorylation levels of Akt, glycogen synthase kinase 3 beta (GSK-3β), and p70 ribosomal S6 kinase (p70S6K) were measured by Western blot.

ST266 significantly improved RPE and MIO-M1 cell viability that was reduced by oxidant exposure and improved oxidant-disrupted Δψm. In both cell types, ST266 induced phosphorylation of Akt, GSK-3β, and p70S6K. MK-2206 significantly eliminated ST266-mediated protein phosphorylation of Akt, GSK-3β, and p70S6K and abolished the ST266-protective effect on cell viability. In conclusion, ST266 activates Akt, protects against oxidative stress-mediated cell injury in an Akt-dependent manner, and improves Δψm, suggesting a potential role for ST266 therapy in treating retinal diseases such as AMD.

新型分泌物 ST266 能激活 Akt 并保护人 RPE 和 Müller 细胞免受氧化应激介导的损伤。
氧化应激介导的视网膜色素上皮(RPE)细胞损伤与老年性黄斑变性(AMD)有关。ST266 是一种新型羊膜源性多能祖细胞产生的生物分泌物。在此,我们研究了 ST266 对由对苯二酚(HQ)(一种与香烟烟雾有关的氧化剂)、过氧化氢(H2O2)和全反式视黄醛(atRal)(视黄醇循环中的一种促氧化剂成分)诱导的 RPE 细胞损伤的影响。我们还研究了它对 H2O2 诱导的 Müller 细胞损伤的影响。在有或没有蛋白激酶 B(Akt)抑制剂 MK-2206 的情况下,将培养的人 RPE 细胞预处理 1 小时,然后用不同浓度的 HQ、H2O2 或 atRal 处理 1.5 小时。培养的人 Müller 细胞(MIO-M1)在有或没有 MK-2206 的情况下预处理 1 小时,然后用不同浓度的 H2O2 处理 1.5 小时。然后在不同时间用 STM100(收集 ST266 分泌组蛋白的对照培养基)或 ST266 更换培养基。细胞活力用 WST-1 试剂测定。线粒体膜电位(Δψm)由荧光平板阅读器量化。通过 Western 印迹检测 Akt、糖原合酶激酶 3 beta (GSK-3β) 和 p70 核糖体 S6 激酶 (p70S6K) 的蛋白磷酸化水平。ST266 能明显改善因暴露于氧化剂而降低的 RPE 和 MIO-M1 细胞活力,并改善氧化剂破坏的 Δψm。在这两种细胞类型中,ST266 都能诱导 Akt、GSK-3β 和 p70S6K 的磷酸化。MK-2206 能明显消除 ST266 介导的 Akt、GSK-3β 和 p70S6K 蛋白磷酸化,并取消 ST266 对细胞活力的保护作用。总之,ST266能激活Akt,以Akt依赖的方式保护细胞免受氧化应激介导的损伤,并改善Δψm,这表明ST266疗法在治疗视网膜疾病(如AMD)方面具有潜在的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experimental eye research
Experimental eye research 医学-眼科学
CiteScore
6.80
自引率
5.90%
发文量
323
审稿时长
66 days
期刊介绍: The primary goal of Experimental Eye Research is to publish original research papers on all aspects of experimental biology of the eye and ocular tissues that seek to define the mechanisms of normal function and/or disease. Studies of ocular tissues that encompass the disciplines of cell biology, developmental biology, genetics, molecular biology, physiology, biochemistry, biophysics, immunology or microbiology are most welcomed. Manuscripts that are purely clinical or in a surgical area of ophthalmology are not appropriate for submission to Experimental Eye Research and if received will be returned without review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信